• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4593037)   Today's Articles (4424)   Subscriber (49318)
Number Citation Analysis
201
Park K, Tan E, O’Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang J, Schuler M, Yamamoto N, Sequist L, Wu Y, Zhou C, Ehrnrooth E, Märten A, Tang W, Paz-Ares L. P3.01-039 Sequential Afatinib-Osimertinib Therapy in EGFR Mutation-Positive (EGFRm+) NSCLC: Analysis of Time on Treatment and OS. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1480] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
202
Satouchi M, Fehrenbacher L, Dols MC, Han J, Von Pawel J, Bordoni R, Hida T, Park K, Moro-Sibilot D, Conkling P, Matheny C, Yu W, He P, Kowanetz M, Gandhi M, Ballinger M, Sandler A, Gandara D. OA 17.07 Long-Term Survival in Atezolizumab-Treated Patients with 2L+ NSCLC from Ph III Randomized OAK Study. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.432] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
203
Nakagawa K, Garon E, Paz-Ares L, Ponce S, Jaime JC, Vidal OJ, Nadal E, Kiura K, Park K, Widau R, Alexandris E, He S, Lee P, Reck M. P3.01-071 Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
204
Cho B, Kim D, Park K, Lee J, Yoo S, Kang J, Lee S, Kim C, Jang S, Kim Y, Yoon H, Kim S. P3.01-050 A Real World Treatment Study of Osimertinib: ASTRIS Study Korean Subgroup Analysis. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
205
Reck M, Shepherd F, Pérol M, Cappuzzo F, Shih J, Park K, Winfree K, Alexandris E, Lee P, Sashegyi A, Garon E. MA 03.06 Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.464] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
206
Schuler M, Yang J, Sequist L, Wu Y, Zhou C, Geater S, Mok T, Tan E, Hu C, Yamamoto N, Feng J, O’Byrne K, Lu S, Hirsh V, Huang Y, Ellis S, Samuelsen C, Märten A, Fan J, Park K, Paz-Ares L. P3.01-026 Analysis of Long-Term Response to First-Line Afatinib in the LUX-Lung 3, 6 and 7 Trials in Advanced EGFRm+ NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
207
Kim H, Shin S, Cho J, Choi Y, Zo J, Shim Y, Park K, Ahn M, Ahn J, Lee S, Sun J, Ahn Y, Pyo H, Noh J, Han J, Kim J. P3.08-006 Treatment Response and Survival Outcomes Are Associated with Histologic Type in Non-Small Cell Lung Cancer Treated with Trimodal Treatment. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
208
Sun J, Lee K, Kim B, Kim H, Min Y, Yi S, Yun H, Lee S, Ahn J, Park K, Ahn M. OA 08.07 Pazopanib Maintenance for Extensive Disease Small Cell Lung Cancer: a Randomized, Placebo-Controlled Phase II study (KCSG-LU12-07). J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
209
Sung W, Park J, Park K. PS06.04 Clinicopathologic Correlation of MACC1 and c-Met Expression in Lung Adenocarcinoma. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
210
Shin S, Cho J, Kim H, Choi Y, Kim J, Zo J, Park K, Ahn M, Ahn J, Sun J, Lee S, Shim Y. P3.01-082 Surgical Rebiopsy in Advanced Non-Small Cell Lung Cancer Resistant to Previous Chemotherapy. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
211
Sequist L, Wu Y, Schuler M, Kato T, Yang J, Tanaka H, Hida T, Lu S, Park K, Paz-Ares L, Laurie S, Bennouna J, Moro Sibilot D, Märten A, Tang W, Ehrnrooth E, Yamamoto N, Nakagawa K. PS02.20 Subsequent Therapies Post-Afatinib Among Patients with EGFR Mutation-Positive (EGFRm+) NSCLC in LUX-Lung 3, 6 and 7. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.058] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
212
Cho B, Obermannová R, Bearz A, Kim D, Orlov S, Borra G, Kim S, Postmus P, Laurie S, Park K, Geater S, Bettini A, Osborne K, Passos V, Chen Z, Dziadziuszko R. OA 05.07 Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.352] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
213
Kye SY, Shim M, Kim YC, Park K. Sharing health information online in South Korea: motives, topics, and antecedents. Health Promot Int 2017;34:182-192. [DOI: 10.1093/heapro/dax074] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
214
Park K, Kim H, Oh B, Lee E, Ha J. 286 Assessment of hair surface roughness by objective analysis. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
215
Park K, Oeda T, Umemura A, Kohsaka M, Tomita S, Sugiyama H, Sawada H. Homeostasis in lipid metabolism is impaired in Parkinson's disease. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
216
Umemura A, Oeda T, Yamamoto K, Kohsaka M, Tomita S, Park K, Sugiyama H, Sawada H. Dementia in Parkinson’s disease is associated with the lateral cholinergic pathway. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
217
Ohara H, Park K, Kosaka M, Umemura A, Tomita S, Tahara M, Yamamoto K, Oeda T, Sugiyama H, Sawada H. Cerebral infarctions with hypereosinophilic syndrome: A report of two cases. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
218
Park W, Kim H, Lee S, Park K. 073_16192-H1 The Quality of Life After Ablative Therapy in Patients with Atrial Fibrillation In Korea. JACC Clin Electrophysiol 2017. [DOI: 10.1016/j.jacep.2017.09.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
219
Song H, Kim Y, Park J, Park M, Lyu S, Koh Y, Heo J, Lee D, Park K. Biocompatible nanoparticle PLGA is a noble safe delivery system for embryo development and next generations. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
220
Park K, Ciardiello F, Hida T, Lim W, Lin CC, Murakami H, Nishio M, Cantero F, Cattan V, Gabarroca C, Gandossi E, Paz-Ares L. Phase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.080] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
221
Reck M, Yang CH, Postmus P, Barlesi F, Font E, Thomas M, Kim T, Cobo Dols M, Skuladottir H, Park K, Sullivan R, Veatch A, Pavlakis N, Dreosti L, Özgüroğlu M, Morgillo F, Schlichting M, Teofilovici F, Chand V, Westeel V. JAVELIN Lung 100: updated design of a phase 3 trial of avelumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+ non-small-cell lung cancer (NSCLC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.078] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
222
Zhang X, Park K, Rizvi N, Dennis P, Narwal R, Huang Y, Arani R, Mukhopadhyay P. Prediction of survival with durvalumab in locally advanced or metastatic NSCLC using early tumor assessments. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
223
Gadgeel S, Kowanetz M, Zou W, Hirsch F, Kerr K, Gandara D, Barlesi F, Park K, McCleland M, Koeppen H, Ballinger M, Sandler A, Hegde P, Rittmeyer A. Clinical efficacy of atezolizumab (Atezo) in PD-L1 subgroups defined by SP142 and 22C3 IHC assays in 2L+ NSCLC: Results from the randomized OAK study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
224
Palmero R, Bidoli P, Bondarenko I, Boyer M, Germonpre P, Ghizdavescu D, Kotsakis A, Lena H, Losonczy G, Park K, Reck M, Su WC, Kallinteris N, Tang M, Lai J, Shan J, Spigel D. Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.065] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
225
Lim S, Sun JM, Hong J, Oh D, Ahn Y, Chung M, Jeong HS, Son YI, Ahn MJ, Baek CH, Park K. Concurrent chemoradiotherapy (CCRT) versus induction docetaxel, cisplatin and 5-fluorouracil (TPF) followed by CCRT in locally advanced hypopharyngeal and base of tongue cancer: A randomized phase II study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx374.032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
226
Sequist L, Wu YL, Schuler M, Kato T, Yang JH, Tanaka H, Hida T, Lu S, Park K, Laurie S, Bennouna J, Moro Sibilot D, Märten A, Peil B, Ehrnrooth E, Yamamoto N, Nakagawa K. Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.051] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
227
Sun JM, Ahn MJ, Ahn J, Kim H, Ahn Y, Zo J, Shim Y, Park K. Randomized phase ii trial comparing chemoradiotherapy with chemotherapy for completely resected unsuspected N2-positive non-small cell lung cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx379.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
228
Yang WC, Xie YT, Zhu WK, Park K, Chen AP, Losovyj Y, Li Z, Liu HM, Starr M, Acosta JA, Tao CG, Li N, Jia QX, Heremans JJ, Zhang SX. Epitaxial thin films of pyrochlore iridate Bi2+xIr2-yO7-δ: structure, defects and transport properties. Sci Rep 2017;7:7740. [PMID: 28798487 PMCID: PMC5552750 DOI: 10.1038/s41598-017-06785-w] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2016] [Accepted: 05/15/2017] [Indexed: 11/09/2022]  Open
229
Lee D, Fontugne J, Gumpeni N, Park K, MacDonald TY, Robinson BD, Sboner A, Rubin MA, Mosquera JM, Barbieri CE. Molecular alterations in prostate cancer and association with MRI features. Prostate Cancer Prostatic Dis 2017;20:430-435. [PMID: 28762374 DOI: 10.1038/pcan.2017.33] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Revised: 05/22/2017] [Accepted: 06/04/2017] [Indexed: 01/08/2023]
230
Lesaffre E, Edelman M, Hanna N, Park K, Thatcher N, Willemsen S, Gaschler-Markefski B, Kaiser R, Manegold C. Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial. Ann Oncol 2017;28:1419-1426. [DOI: 10.1093/annonc/mdx042] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Indexed: 11/13/2022]  Open
231
Kim Y, Lee H, Park B, Park K. PREDICTING HEALTH LITERACY AMONG DISABLED ELDERLY IN KOREA: IMPLICATIONS FOR HEALTH JUSTICE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
232
Park Y, Son D, Park K, Park E, Choi Y. FACTORS AFFECTING EARLY DETECTION OF MENTAL HEALTH PROBLEMS OF THE ELDERLY AND SERVICE USE IN KOREA. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
233
Alam J, Koh JH, Kwok SK, Park SH, Park K, Choi Y. Functional Epitopes for Anti-Aquaporin 5 Antibodies in Sjögren Syndrome. J Dent Res 2017;96:1414-1421. [PMID: 28665757 DOI: 10.1177/0022034517717965] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
234
Ho D, Peng P, Bass C, Collins P, D'Angelo A, Deur A, Fleming J, Hanretty C, Kageya T, Khandaker M, Klein FJ, Klempt E, Laine V, Lowry MM, Lu H, Nepali C, Nikonov VA, O'Connell T, Sandorfi AM, Sarantsev AV, Schumacher RA, Strakovsky II, Švarc A, Walford NK, Wei X, Whisnant CS, Workman RL, Zonta I, Adhikari KP, Adikaram D, Akbar Z, Amaryan MJ, Anefalos Pereira S, Avakian H, Ball J, Bashkanov M, Battaglieri M, Batourine V, Bedlinskiy I, Biselli A, Briscoe WJ, Burkert VD, Carman DS, Celentano A, Charles G, Chetry T, Ciullo G, Clark L, Colaneri L, Cole PL, Contalbrigo M, Crede V, Dashyan N, De Sanctis E, De Vita R, Djalali C, Dupre R, El Alaoui A, El Fassi L, Elouadrhiri L, Eugenio P, Fedotov G, Fegan S, Fersch R, Filippi A, Fradi A, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Gleason C, Gohn W, Golovatch E, Gothe RW, Griffioen KA, Guidal M, Guo L, Hakobyan H, Harrison N, Hattawy M, Hicks K, Holtrop M, Hughes SM, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jenkins D, Jiang H, Jo HS, Joo K, Joosten S, Keller D, Khachatryan G, Kim A, Kim W, Klein A, Kubarovsky V, Kuleshov SV, Lanza L, Lenisa P, Livingston K, MacGregor IJD, Markov N, McKinnon B, Mineeva T, Mokeev V, Montgomery RA, Movsisyan A, Munoz Camacho C, Murdoch G, Niccolai S, Niculescu G, Osipenko M, Paolone M, Paremuzyan R, Park K, Pasyuk E, Phelps W, Pogorelko O, Price JW, Procureur S, Protopopescu D, Ripani M, Riser D, Ritchie BG, Rizzo A, Rosner G, Sabatié F, Salgado C, Sharabian YG, Skorodumina I, Smith GD, Sober DI, Sokhan D, Sparveris N, Strauch S, Tian Y, Torayev B, Ungaro M, Voskanyan H, Voutier E, Watts DP, Wood MH, Zachariou N, Zhang J, Zhao ZW. Beam-Target Helicity Asymmetry for γ[over →]n[over →]→π^{-}p in the N^{*} Resonance Region. PHYSICAL REVIEW LETTERS 2017;118:242002. [PMID: 28665642 DOI: 10.1103/physrevlett.118.242002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2017] [Indexed: 06/07/2023]
235
Szczepny A, Rogers S, Jayasekara WSN, Park K, McCloy RA, Cochrane CR, Ganju V, Cooper WA, Sage J, Peacock CD, Cain JE, Burgess A, Watkins DN. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer. Oncogene 2017;36:5544-5550. [PMID: 28581526 PMCID: PMC5623150 DOI: 10.1038/onc.2017.173] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2016] [Revised: 04/27/2017] [Accepted: 04/27/2017] [Indexed: 02/07/2023]
236
Koh Y, Byun J, Kim Y, Lee D, Park K, Yoon S, Bea G, Kim D. REDEFINING THE ROLE OF ETOPOSIDE IN PERIPHERAL T-CELL LYMPHOMA TREATMENT. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
237
Kim JM, Choi S, Park K. TRPM7 Is Involved in Volume Regulation in Salivary Glands. J Dent Res 2017;96:1044-1050. [PMID: 28499095 DOI: 10.1177/0022034517708766] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]  Open
238
Jung J, Hur Y, Lim C, Shin K, Kim H, Chung H, Park K. 596 ICP-5249 attenuates psoriatic inflammation through autophagy. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
239
Na J, Choi J, Huh C, Shin J, Park K. 656 Changes of lesional and non-lesional skin microbiome in the treatment course of atopic dermatitis. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
240
Park H, Shin K, Kim J, Ahn S, Kim S, Kim Y, Park W, Kim Y, Shin S, Kim J, Lee S, Kim K, Park K, Jeong B. PV-0235: Is there a subset who benefits from PMRT in node-negative breast cancer patients? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30678-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
241
Kim K, Cho Y, Shin K, Lee Y, Yokota M, Chae S, Park K, Uchida Y. 414 Both sphingosine kinase 1 and 2 coordinately regulate cathelicidin antimicrobial peptide production during keratinocyte differentiation. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
242
Yoo G, Oh D, Noh J, Ahn Y, Baek C, Son Y, Jeong H, Sun J, Ahn M, Park K. EP-1070: Concurrent chemoradiation versus upfront surgery for clinical T3-4 hypopharynx and larynx cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31506-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
243
Gupta S, Iv V, Klaric K, Park K. Impact of Helmet Usage on Clinical Presentation and Outcome of Traumatic Brain Injury in Motorcycle Operators in Cambodia. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
244
Garassino M, Cho BC, Gray J, Mazières J, Park K, Soo R, Dennis P, Huang Y, Wadsworth C, Rizvi N. Durvalumab in ≥ 3rd-line EGFR mutant/ALK+, locally advanced or metastatic NSCLC: Results from the phase 2 ATLANTIC study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.002] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
245
Cho E, Kang J, Han JY, Lee J, Kim DW, Kim SW, Min Y, Lee K, Kim JH, Park K. Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
246
Yang JH, Paz-Ares L, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Fan J, Park K. Afatinib vs gefitinib for treatment-naïve patients with EGFRm+ NSCLC (LUX-Lung 7): Analysis of time to treatment failure and impact of afatinib dose adjustment. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
247
Schuler M, Paz-Ares L, Sequist L, Wu YL, Geater S, Märten A, Fan J, Park K, Yang JH. First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trials. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
248
Hofmeyr R, McGuire J, Douglas-Jones P, Proxenos M, Park K, Lubbe D. Multilevel dilatation of tracheal and bronchial stenosis using a non-occlusive tracheal dilatation balloon in a patient with sclerosing airway disease. J Cardiothorac Vasc Anesth 2017. [DOI: 10.1053/j.jvca.2017.02.066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
249
Hofmeyr R, McGuire J, Marwick P, Park K, Proxenos M, Lehmann M, Weich H. Continuous ventilation during tracheal dilatation using a novel, non-occlusive tracheal balloon dilator in an ovine model. J Cardiothorac Vasc Anesth 2017. [DOI: 10.1053/j.jvca.2017.02.173] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
250
Artal-Cortes A, Mazieres J, Fehrenbacher L, Rittmeyer A, Spira A, Park K, Lewanski C, Liu S, Ballinger M, Vansteenkiste J. Evaluation of non-classical response by immune-modified RECIST and efficacy of atezolizumab beyond disease progression in advanced NSCLC: Results from the randomized Phase II study POPLAR. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx091.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 5 of 25 124562425Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA